Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
The Journal of Urology
|
February 29, 2024
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy
Todd M Morgan, Stephen A Boorjian, Mark K Buyyounouski, et al.
NPJ Precision Oncology
|
July 9, 2025
Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancer
Karl Semaan, Rashad Nawfal, John Canniff, et al.
JAMA Oncology
|
August 28, 2020
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial
Jonathan D Schoenfeld, Glenn J Hanna, Vickie Y Jo, et al.
Science Advances
|
April 29, 2022
Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy
Thomas S C Ng, Huiyu Hu, Stefan Kronister, et al.
Cancer Immunology Research
|
March 29, 2024
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer
Atish D Choudhury, Lucia Kwak, Alexander Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2023
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP
Jennifer K Litton, Meredith M Regan, Lajos Pusztai, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
The Journal of Urology
|
February 29, 2024
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy
Todd M Morgan, Stephen A Boorjian, Mark K Buyyounouski, et al.
NPJ Precision Oncology
|
July 9, 2025
Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancer
Karl Semaan, Rashad Nawfal, John Canniff, et al.
JAMA Oncology
|
August 28, 2020
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial
Jonathan D Schoenfeld, Glenn J Hanna, Vickie Y Jo, et al.
Science Advances
|
April 29, 2022
Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy
Thomas S C Ng, Huiyu Hu, Stefan Kronister, et al.
Cancer Immunology Research
|
March 29, 2024
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer
Atish D Choudhury, Lucia Kwak, Alexander Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2023
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP
Jennifer K Litton, Meredith M Regan, Lajos Pusztai, et al.
Page
of 8